Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection

PloS One
Katherine SullivanTomasz Skorski

Abstract

It has been reported that inhibition of RAD52 either by specific shRNA or a small peptide aptamer induced synthetic lethality in tumor cell lines carrying BRCA1 and BRCA2 inactivating mutations. Molecular docking was used to screen two chemical libraries: 1) 1,217 FDA approved drugs, and 2) 139,735 drug-like compounds to identify candidates for interacting with DNA binding domain of human RAD52. Thirty six lead candidate compounds were identified that were predicted to interfere with RAD52 -DNA binding. Further biological testing confirmed that 9 of 36 candidate compounds were able to inhibit the binding of RAD52 to single-stranded DNA in vitro. Based on molecular binding combined with functional assays, we propose a model in which the active compounds bind to a critical "hotspot" in RAD52 DNA binding domain 1. In addition, one of the 9 active compounds, adenosine 5'-monophosphate (A5MP), and also its mimic 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) 5' phosphate (ZMP) inhibited RAD52 activity in vivo and exerted synthetic lethality against BRCA1 and BRCA2-mutated carcinomas. These data suggest that active, inhibitory RAD52 binding compounds could be further refined for efficacy and safety to develop drugs inducing sy...Continue Reading

References

Jan 15, 2000·Molecular Cell·R ScullyD M Livingston
Mar 28, 2002·Cellular and Molecular Life Sciences : CMLS·B Elliott, M Jasin
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Martin R SingletonDale B Wigley
Oct 16, 2004·Molecular and Cellular Biology·Jeremy M StarkMaria Jasin
Apr 4, 2006·Drug Discovery Today·Ivan C Baines, Pierre Colas
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
Jul 3, 2008·The Journal of Biological Chemistry·Wataru KagawaShigeyuki Yokoyama
Sep 2, 2009·Journal of Medicinal Chemistry·John J IrwinYiqun Cao
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Zhihui FengSimon N Powell
Jan 6, 2011·CA: a Cancer Journal for Clinicians·Timothy A YapJohann S de Bono
Oct 25, 2011·Blood·Eliza VakanaLeonidas C Platanias
Feb 22, 2012·Nature Biotechnology·Elisabet WahlbergJohan Weigelt
Mar 24, 2012·Journal of the American Chemical Society·Rainer WilckenFrank M Boeckler
May 11, 2012·Nucleic Acids Research·Brian BudkePhilip P Connell
Mar 1, 2010·Expert Opinion on Drug Discovery·Michael J Waring
Sep 4, 2012·Methods in Molecular Biology·Amanda Gunn, Jeremy M Stark
Sep 4, 2013·Chemical Biology & Drug Design·Theresa TiefenbrunnCharles D Stout
Nov 10, 2015·Chemistry & Biology·Gurushankar ChandramoulyRichard T Pomerantz

❮ Previous
Next ❯

Citations

Mar 21, 2016·Medical Oncology·Y C Lim, A P Wiegmans
Sep 21, 2016·Genes·Kritika HanamshetAlexander V Mazin
Jan 6, 2017·Journal of Cancer Prevention·Azad KumarNilesh Kumar Sharma
May 19, 2017·Journal of the National Cancer Institute·Jac A NickoloffRobert Hromas
Dec 17, 2016·Molecular Cell·Rahul BhowmickIan D Hickson
May 30, 2017·The Journal of Biological Chemistry·Chu Jian MaEric C Greene
Nov 18, 2017·Breast Cancer Research : BCR·Robert HromasKimi Y Kong
Feb 10, 2018·Current Medicinal Chemistry·Monika TomaTomasz Sliwinski
Oct 24, 2018·International Journal of Molecular Sciences·Margarita RomeoRicard Mesía
Dec 22, 2019·Cancers·Camille Franchet, Jean-Sébastien Hoffmann
May 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anu PrakashEmer Bourke
Jul 26, 2019·Cancers·Manisha JalanSimon N Powell
Jul 10, 2020·Journal of Biomolecular Structure & Dynamics·H PrabhavathiH Raja Naika
Sep 10, 2019·International Journal of Cancer. Journal International Du Cancer·Masaoki KohzakiRyuji Okazaki
Dec 5, 2019·Nucleic Acids Research·Barbora StefanovieLumir Krejci
Feb 27, 2020·International Journal of Molecular Sciences·Antonio MaffiaSimone Sabbioneda
Apr 27, 2021·British Journal of Pharmacology·Liliana RaimundoLucília Saraiva
Jun 14, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ying Chen, Hui Du

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
x-ray crystallography

Software Mentioned

DOCK6
OEDocking
VIDA
SPHGEN
Make Receptor
AICAR
Omega
Openeye

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.